Nang Kuang Pharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	345.67	301.54	378.48	401.2	417.12
Trading Asset Securities	-	-	-	1.31	1.28
Cash & Short-Term Investments	345.67	301.54	378.48	402.51	418.41
Cash Growth	14.63%	-20.33%	-5.97%	-3.80%	56.21%
Accounts Receivable	363.56	423.08	374.67	386.71	350.44
Other Receivables	0.98	0.12	1.3	0.15	0.4
Receivables	364.54	423.2	375.97	386.86	350.84
Inventory	663.38	709.06	762.62	827.58	701.44
Prepaid Expenses	92.41	20.36	20.61	23.38	20.71
Other Current Assets	26.61	1.83	-	-	-
Total Current Assets	1,493	1,456	1,538	1,640	1,491
Property, Plant & Equipment	2,089	2,105	1,867	1,602	1,682
Long-Term Investments	136.81	129.12	152.18	118.97	50.29
Other Intangible Assets	5.28	4.34	5.2	3.87	5.21
Long-Term Deferred Tax Assets	25.39	22.02	39.36	27.07	29.84
Other Long-Term Assets	74.68	95.99	255.08	192.61	169.83
Total Assets	3,823	3,813	3,856	3,585	3,429
Accounts Payable	211.55	210.38	166.8	254.3	224.34
Accrued Expenses	-	113.99	100.61	-	-
Short-Term Debt	460	450	580	370	479.99
Current Portion of Long-Term Debt	11.46	19.86	12.5	12.5	12.5
Current Portion of Leases	0.37	0.75	0.49	1.05	1.26
Current Income Taxes Payable	22.64	11.78	2.7	57.01	46.61
Current Unearned Revenue	121.42	123.9	127.97	142.49	131.55
Other Current Liabilities	237.35	212.17	291.63	203.04	176.7
Total Current Liabilities	1,065	1,143	1,283	1,040	1,073
Long-Term Debt	186.39	167.26	112.5	25	37.5
Long-Term Leases	-	0.37	0.07	0.59	1.55
Pension & Post-Retirement Benefits	-	50.01	53.71	53	53.36
Long-Term Deferred Tax Liabilities	0.68	0.35	-	1.2	0.26
Other Long-Term Liabilities	81.85	30.1	30.1	53.33	23.06
Total Liabilities	1,334	1,391	1,479	1,174	1,189
Common Stock	1,010	1,010	1,010	1,010	1,010
Additional Paid-In Capital	245.01	325.8	426.79	457.09	482.34
Retained Earnings	1,229	1,086	940.46	944.03	748.02
Comprehensive Income & Other	-0.04	-0.04	-0.03	0.02	-0.04
Total Common Equity	2,484	2,422	2,377	2,411	2,240
Minority Interest	5.53	-	-	-	-
Shareholders' Equity	2,490	2,422	2,377	2,411	2,240
Total Liabilities & Equity	3,823	3,813	3,856	3,585	3,429
Total Debt	658.21	638.23	705.56	409.13	532.81
Net Cash (Debt)	-312.54	-336.69	-327.08	-6.62	-114.4
Net Cash Per Share	-3.08	-3.33	-3.23	-0.07	-1.13
Filing Date Shares Outstanding	101.02	100.99	100.99	100.99	100.99
Total Common Shares Outstanding	101.02	100.99	100.99	100.99	100.99
Working Capital	427.82	313.17	254.99	599.94	418.44
Book Value Per Share	24.59	23.98	23.54	23.87	22.18
Tangible Book Value	2,479	2,418	2,372	2,407	2,235
Tangible Book Value Per Share	24.54	23.94	23.49	23.84	22.13
Land	-	767.41	573.57	247.28	247.28
Buildings	-	1,232	1,134	1,120	1,111
Machinery	-	2,586	2,506	2,431	2,359
Construction In Progress	-	56.54	26.79	36.53	41.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.